191 related articles for article (PubMed ID: 9361057)
1. Intraventricular immunotoxin therapy for leptomeningeal neoplasia.
Laske DW; Muraszko KM; Oldfield EH; DeVroom HL; Sung C; Dedrick RL; Simon TR; Colandrea J; Copeland C; Katz D; Greenfield L; Groves ES; Houston LL; Youle RJ
Neurosurgery; 1997 Nov; 41(5):1039-49; discussion 1049-51. PubMed ID: 9361057
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and toxicology of immunotoxins administered into the subarachnoid space in nonhuman primates and rodents.
Muraszko K; Sung C; Walbridge S; Greenfield L; Dedrick RL; Oldfield EH; Youle RJ
Cancer Res; 1993 Aug; 53(16):3752-7. PubMed ID: 8339287
[TBL] [Abstract][Full Text] [Related]
3. Restoration of interferon alpha potentiation of a recombinant ricin A chain immunotoxin following cytoreduction of xenografts of advanced ovarian tumors.
Pearson JW; Fogler WE; Volker K; Riggs CW; Gruys E; Groves ES; Wiltrout RH; Longo DL
J Natl Cancer Inst; 1993 Jun; 85(11):907-12. PubMed ID: 8492319
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice.
Laske DW; Ilercil O; Akbasak A; Youle RJ; Oldfield EH
J Neurosurg; 1994 Mar; 80(3):520-6. PubMed ID: 8113865
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human tumor growth by intraperitoneal immunotoxins in nude mice.
Marks A; Ettenson D; Bjorn MJ; Lei M; Baumal R
Cancer Res; 1990 Jan; 50(2):288-92. PubMed ID: 2295069
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hematopoietic progenitor colony growth by a monoclonal antibody against the transferrin receptor: comparison of unconjugated antibody with an immunotoxin containing recombinant ricin A chain.
Shannon KM; Ring DB; Houston LL; Schaffner V; Naylor J; Torkildson JC; Reid SA; Larrick J
Int J Cell Cloning; 1990 Sep; 8(5):368-76. PubMed ID: 2230286
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of an immunotoxin in a nude mouse model of human ovarian cancer.
FitzGerald DJ; Bjorn MJ; Ferris RJ; Winkelhake JL; Frankel AE; Hamilton TC; Ozols RF; Willingham MC; Pastan I
Cancer Res; 1987 Mar; 47(5):1407-10. PubMed ID: 3493065
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human corneal epithelium with immunotoxin 454A12-rRA.
Fulcher SF; Foulks GN; Wilkerson M; Cobo LM; Jaffe GJ; Hatchell DL
Cornea; 1992 Sep; 11(5):413-7. PubMed ID: 1424670
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain.
Masui H; Kamrath H; Apell G; Houston LL; Mendelsohn J
Cancer Res; 1989 Jul; 49(13):3482-8. PubMed ID: 2786451
[TBL] [Abstract][Full Text] [Related]
10. In vitro cytotoxicity of recombinant ricin A chain-antitransferrin receptor immunotoxin against human adenocarcinomas of the colon and pancreas.
Griffin TW; Pagnini PG; McGrath JJ; McCann JC; Houston LL
J Biol Response Mod; 1988 Dec; 7(6):559-67. PubMed ID: 3265147
[TBL] [Abstract][Full Text] [Related]
11. Enhanced therapeutic efficacy against an ovarian tumor xenograft of immunotoxins used in conjunction with recombinant alpha-interferon.
Pearson JW; Hedrick E; Fogler WE; Bull RL; Ferris DK; Riggs CW; Wiltrout RH; Sivam G; Morgan AC; Groves E
Cancer Res; 1990 Oct; 50(19):6379-88. PubMed ID: 2144790
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of proliferating lens epithelium with antitransferrin receptor immunotoxin.
Goins KM; Ortiz JR; Fulcher SF; Handa JT; Jaffe GJ; Foulks GN; Cobo LM
J Cataract Refract Surg; 1994 Sep; 20(5):513-6. PubMed ID: 7996406
[TBL] [Abstract][Full Text] [Related]
13. A combination of two immunotoxins exerts synergistic cytotoxic activity against human breast-cancer cell lines.
Crews JR; Maier LA; Yu YH; Hester S; O'Briant K; Leslie DS; DeSombre K; George SL; Boyer CM; Argon Y
Int J Cancer; 1992 Jul; 51(5):772-9. PubMed ID: 1351885
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of intrathecal immunotoxin therapy in an animal model of leptomeningeal neoplasia.
Zovickian J; Youle RJ
J Neurosurg; 1988 May; 68(5):767-74. PubMed ID: 3258632
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of transferrin receptor-targeted immunotoxins in brain tumor cell lines and pediatric brain tumors.
Martell LA; Agrawal A; Ross DA; Muraszko KM
Cancer Res; 1993 Mar; 53(6):1348-53. PubMed ID: 8443815
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of intrathecal transferrin-ricin a chain immunotoxin.
Candiani C; Tommasi M; Fracasso G; Lorenzetti I; Adami A; Benoni G; Tridente G; Colombatti M
Life Sci; 2001 Jun; 69(3):335-46. PubMed ID: 11441924
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of growing pigment epithelial cells by a receptor-directed immunotoxin.
Davis AA; Whidby DE; Privette T; Houston LL; Hunt RC
Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2514-9. PubMed ID: 2265991
[TBL] [Abstract][Full Text] [Related]
18. Phase I evaluation of an anti-breast carcinoma monoclonal antibody 260F9-recombinant ricin A chain immunoconjugate.
Weiner LM; O'Dwyer J; Kitson J; Comis RL; Frankel AE; Bauer RJ; Konrad MS; Groves ES
Cancer Res; 1989 Jul; 49(14):4062-7. PubMed ID: 2786751
[TBL] [Abstract][Full Text] [Related]
19. Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxin.
Zovickian J; Johnson VG; Youle RJ
J Neurosurg; 1987 Jun; 66(6):850-61. PubMed ID: 3033171
[TBL] [Abstract][Full Text] [Related]
20. Phase I trial of an anti-CD19 deglycosylated ricin A chain immunotoxin in non-Hodgkin's lymphoma: effect of an intensive schedule of administration.
Conry RM; Khazaeli MB; Saleh MN; Ghetie V; Vitetta ES; Liu T; LoBuglio AF
J Immunother Emphasis Tumor Immunol; 1995 Nov; 18(4):231-41. PubMed ID: 8680651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
